Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

49.75
Delayed Data
As of Aug 23
 +0.25 / +0.51%
Today’s Change
30.93
Today|||52-Week Range
54.96
+30.37%
Year-to-Date
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Aug 19 / Zacks.com - Paid Partner Content
Xenetic's IND to Start Phase II Virexxa Study Accepted in U.S.
Aug 22 / Zacks.com - Paid Partner Content
Why You Shouldn't Bet Against Anika Therapeutics (ANIK) Stock
Aug 17 / Zacks.com - Paid Partner Content
Portola IndexXa's Regulatory Application Validated in the EU
Aug 22 / Zacks.com - Paid Partner Content
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Aug 17 / Zacks.com - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
Radius (RDUS) Osteoporosis Drug Positive in Phase III Study
Aug 17 / Zacks.com - Paid Partner Content
Aclaris (ACRS) Common Warts Candidate Positive in Phase II
Aug 19 / Zacks.com - Paid Partner Content
Actelion (ALIOF) Uptravi Approved for PAH in Switzerland
Aug 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.50
Today’s open49.89
Day’s range49.65 - 50.08
Volume82,733
Average volume (3 months)152,934
Market cap$731.5M
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)-0.66%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-11.93%
P/E ratio21.7
Price/Sales6.29
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
CERSCerus Corp-0.11-1.60%
KTWOK2M Group Holdings I...-0.37-2.21%
NVCRNovocure Ltd-0.07-0.88%
CSIICardiovascular Syste...+0.48+2.01%
Data as of 08/23/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers

Search for Jobs